These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34747452)

  • 1. Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry.
    Alevizos MK; Danoff SK; Pappas DA; Lederer DJ; Johnson C; Hoffman EA; Bernstein EJ; Bathon JM; Giles JT
    Rheumatology (Oxford); 2022 Jul; 61(7):2792-2804. PubMed ID: 34747452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.
    Bernstein EJ; Barr RG; Austin JHM; Kawut SM; Raghu G; Sell JL; Hoffman EA; Newell JD; Watts JR; Nath PH; Sonavane SK; Bathon JM; Majka DS; Lederer DJ
    Thorax; 2016 Dec; 71(12):1082-1090. PubMed ID: 27609750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis.
    Johnson C; Giles JT; Bathon J; Lederer D; Hoffman EA; Barr RG; Danoff SK
    PLoS One; 2016; 11(4):e0153024. PubMed ID: 27050433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Juge PA; Granger B; Debray MP; Ebstein E; Louis-Sidney F; Kedra J; Doyle TJ; Borie R; Constantin A; Combe B; Flipo RM; Mariette X; Vittecoq O; Saraux A; Carvajal-Alegria G; Sibilia J; Berenbaum F; Kannengiesser C; Boileau C; Sparks JA; Crestani B; Fautrel B; Dieudé P
    Arthritis Rheumatol; 2022 Nov; 74(11):1755-1765. PubMed ID: 35583934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.
    Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z
    Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.
    Wheeler AM; Baker JF; Poole JA; Ascherman DP; Yang Y; Kerr GS; Reimold A; Kunkel G; Cannon GW; Wysham KD; Singh N; Lazaro D; Monach P; Bridges SL; Mikuls TR; England BR
    Semin Arthritis Rheum; 2022 Dec; 57():152098. PubMed ID: 36155967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
    Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y
    Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Computed Tomography Densitometry with Disease Severity, Functional Decline, and Survival in Systemic Sclerosis-associated Interstitial Lung Disease.
    Saldana DC; Hague CJ; Murphy D; Coxson HO; Tschirren J; Peterson S; Sieren JP; Kirby M; Ryerson CJ
    Ann Am Thorac Soc; 2020 Jul; 17(7):813-820. PubMed ID: 32191491
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.
    Restrepo JF; del Rincón I; Battafarano DF; Haas RW; Doria M; Escalante A
    Clin Rheumatol; 2015 Sep; 34(9):1529-36. PubMed ID: 26255186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and radiological characteristics of rheumatoid arthritis-associated interstitial lung disease in a multi-ethnic Malaysian cohort.
    Ong SG; Ding HJ; Zuhanis AH; Aida AA; Norazizah IW
    Med J Malaysia; 2022 May; 77(3):292-299. PubMed ID: 35638484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients.
    Wang JX; Du CG
    Med Sci Monit; 2015 Mar; 21():708-15. PubMed ID: 25746669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study.
    Wu X; Xu L; Cheng Q; Nie L; Zhang S; Du Y; Xue J
    Respir Med; 2020 May; 166():105948. PubMed ID: 32250876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of symptomatic diffuse interstitial lung disease in rheumatoid arthritis in a Spanish population.
    Bonilla Hernán MG; Gómez-Carrera L; Fernández-Velilla Peña M; Álvarez-Sala Walther R; Balsa A
    Rev Clin Esp (Barc); 2022 May; 222(5):281-287. PubMed ID: 34583914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.